anmelden
NASDAQ Composite Index
26.650,75
PKT
+109,40
PKT
+0,41
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NASDAQ Composite Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.05.12 | Ultra Clean hold | Needham & Company, LLC | |
| 15.05.12 | Applied Materials hold | Needham & Company, LLC | |
| 15.05.12 | NVIDIA equal-weight | Barclays Capital | |
| 15.05.12 | OraSure Technologies buy | Barrington Research | |
| 11.05.12 | Apple overweight | Morgan Stanley | |
| 11.05.12 | Intel buy | UBS AG | |
| 11.05.12 | Amazon halten | Der Aktionär | |
| 10.05.12 | Teva Pharmaceutical Industries buy | UBS AG | |
| 10.05.12 | Teva Pharmaceutical Industries hold | Needham & Company, LLC | |
| 10.05.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
| 10.05.12 | Intel outperform | RBC Capital Markets | |
| 10.05.12 | Alexion Pharmaceuticals overweight | Barclays Capital | |
| 10.05.12 | Biogen buy | UBS AG | |
| 10.05.12 | Ceragon Networks outperform | RBC Capital Markets | |
| 09.05.12 | NuVasive overweight | Barclays Capital | |
| 09.05.12 | Deckers Outdoor overweight | Barclays Capital | |
| 09.05.12 | Bed Bath Beyond overweight | Barclays Capital | |
| 09.05.12 | Apple overweight | Barclays Capital | |
| 09.05.12 | Wynn Resorts overweight | Barclays Capital | |
| 09.05.12 | Vertex Pharmaceuticals overweight | Barclays Capital | |
| 08.05.12 | Wynn Resorts buy | UBS AG | |
| 08.05.12 | Vertex Pharmaceuticals buy | Needham & Company, LLC | |
| 08.05.12 | BlackBerry neutral | UBS AG | |
| 07.05.12 | Applied Materials neutral | UBS AG | |
| 07.05.12 | Abbott Laboratories outperform | RBC Capital Markets | |
| 07.05.12 | Intel buy | UBS AG | |
| 07.05.12 | Amazon outperform | RBC Capital Markets | |
| 07.05.12 | Visa outperform | RBC Capital Markets | |
| 10.05.12 | Dish Network outperform | RBC Capital Markets | |
| 07.05.12 | Garmin sector perform | RBC Capital Markets | |
| 07.05.12 | Microsoft overweight | Barclays Capital | |
| 07.05.12 | Royal Gold sector perform | RBC Capital Markets | |
| 07.05.12 | Ross Stores sector perform | RBC Capital Markets | |
| 07.05.12 | Oracle buy | Stifel, Nicolaus & Co., Inc. | |
| 07.05.12 | Power Integrations buy | Needham & Company, LLC | |
| 04.05.12 | Microsoft buy | Stifel, Nicolaus & Co., Inc. | |
| 04.05.12 | Intel buy | Sarasin Research | |
| 04.05.12 | Royal Gold buy | UBS AG | |
| 04.05.12 | Microchip Technology buy | Nomura | |
| 04.05.12 | Teva Pharmaceutical Industries outperform | Exane-BNP Paribas SA |
